Markets2 min read

Healthcare Payment Tech Sees Major Institutional Exit in Q1

Capricorn Fund Managers liquidates $18.4M position in Waystar as healthcare fintech faces investor scrutiny amid market volatility.

April 24, 2026 at 4:47 PMCannabismarketcap

Capricorn Fund Managers executed an $18.4 million divestiture of Waystar holdings during the first quarter, marking one of the larger institutional exits from the healthcare payment technology sector this year. The fund's decision to liquidate its position comes as healthcare fintech companies face increased scrutiny over valuation metrics and growth sustainability in a challenging capital environment.

Waystar operates a cloud-based payment infrastructure serving healthcare providers, processing transactions that support over $1 billion in annual client revenue through its software-as-a-service platform. The company's business model relies on recurring subscription fees and transaction-based revenue streams, positioning it within the broader healthcare technology ecosystem that has experienced significant volatility over the past 18 months.

The institutional selloff reflects broader market dynamics affecting B2B software companies, particularly those serving the healthcare sector. Healthcare payment processors have faced headwinds from regulatory changes, reimbursement pressures, and increased competition from both established financial services firms and emerging fintech startups targeting medical billing workflows.

Capricorn's exit strategy suggests institutional investors are reassessing exposure to mid-tier healthcare technology plays amid concerns over customer acquisition costs and market saturation. The timing of the divestiture coincides with broader institutional portfolio rebalancing as fund managers navigate elevated interest rates and tighter credit conditions affecting growth-stage technology investments.

This institutional movement highlights the ongoing consolidation pressure within healthcare fintech, where scale advantages and regulatory compliance costs favor larger players. Smaller specialized providers face increasing pressure to demonstrate clear paths to profitability as institutional capital becomes more selective in deployment across the healthcare technology landscape.